XML 15 R15.htm IDEA: XBRL DOCUMENT v3.20.1
Earnings (Loss) Per Share
9 Months Ended
Feb. 29, 2020
Earnings Per Share [Abstract]  
Earnings (Loss) Per Share EARNINGS (LOSS) PER SHARE
 
The following table summarizes the reconciliation of the numerators and denominators for the basic and diluted earnings (loss) per share computation for the periods indicated:
 
Three months ended
 
Nine months ended
 
February 29,
 
February 28,
 
February 29,
 
February 28,
 
2020
 
2019
 
2020
 
2019
Net income (loss) attributable to Class A and Common Stockholders
$(43.3)
 
$(12.6)
 
$(30.8)
 
$(2.3)
Weighted average Shares of Class A Stock and Common Stock outstanding for basic earnings (loss) per share (in millions)
34.5
 
35.3
 
34.8
 
35.2
Dilutive effect of Class A Stock and Common Stock potentially issuable pursuant to stock-based compensation plans (in millions) *

 

 

 

Adjusted weighted average Shares of Class A Stock and Common Stock outstanding for diluted earnings (loss) per share (in millions)
34.5
 
35.3
 
34.8
 
35.2
Earnings (loss) per share of Class A Stock and Common Stock:
 

 
 

 
 

 
 

Basic
$(1.25)
 
$(0.36)
 
$(0.89)
 
$(0.07)
Diluted
$(1.25)
 
$(0.36)
 
$(0.89)
 
$(0.07)


* The Company experienced a net loss for all periods presented and therefore did not report any dilutive share impact.

The following table sets forth options outstanding pursuant to stock-based compensation plans as of the dates indicated: 
 
February 29, 2020
 
February 28, 2019
Options outstanding pursuant to stock-based compensation plans (in millions)
3.0
 
2.9


A portion of the Company’s Restricted Stock Units ("RSUs") which are granted to employees participate in earnings through cumulative dividends which are payable and non-forfeitable to the employees upon vesting of the RSUs. Accordingly, the Company measures earnings per share based upon the lower of the Two-class method or the Treasury Stock method.

For the three and nine months ended February 29, 2020 and February 28, 2019, respectively, the Company experienced a net loss for all periods presented and did not allocate any losses to the participating securities.

There were 2.2 million of potentially anti-dilutive shares pursuant to stock-based compensation plans as of February 29, 2020.

As of February 29, 2020, $20.1 remained available for future purchases of common shares under the repurchase authorization of the Board of Directors (the "Board") in effect on that date. See Note 13, Treasury Stock, for a more complete description of the Company’s share buy-back program.